BrainEver
BrainEver's platform treats neurodegenerative diseases based on Homeoproteins (HPs). .
Get premium to view all results
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
Related Content
Notes (0)
More about BrainEver
EditOperator of a medical research agency intended to develop drugs for the treatment of neurodegenerative disorders. The company's services specialize in the research and development of novel therapeutics using specific proprietary proteins to treat Parkinson's, amyotrophic lateral sclerosis, and Huntington's diseases, enabling healthcare practitioners to avail of drugs while providing the required treatment efficiently.
Keywords: Pharmaceuticals and Biotechnology, Drug Research Center, Drug Research Process, Homeoprotein Administration, Medical Research Agency, Neurodegenerative Disorder, Novel Therapeutics.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.